Fig. 6From: The utility of the standardized uptake value, metabolic tumor volume and total lesion glycolysis as predictive markers of recurrent breast cancerAxial CT, PET and MIP Fused PET-CT. Patient with recurrent locoregional tumor (SUVmax: 15.20) and ipsilateral lymph node metastasis (stage IIIB)Back to article page